DETERMINATION OF C3A RELEASED UPON ACTIVATION OF COMPLEMENT SYSTEM

Anti-C3a antibody preparation characterized in that in its reaction with C3a it is substantially not inhibited by C3 so that it can be employed for C3a assays, for example in plasma samples, in the presence of native C3; and the use of the preparation for determining C3a by immunochemical assay. The...

Full description

Saved in:
Bibliographic Details
Main Authors ULF R. NILSSON, S.I. BO NILSSON, KARL-ERIK SVENSSON
Format Patent
LanguageEnglish
Published 09.08.1990
Edition5
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Anti-C3a antibody preparation characterized in that in its reaction with C3a it is substantially not inhibited by C3 so that it can be employed for C3a assays, for example in plasma samples, in the presence of native C3; and the use of the preparation for determining C3a by immunochemical assay. The invention is based on newly discovered neoantigens.
Bibliography:Application Number: AU19870070623